Seven Eight Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Seven Eight Capital’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,020	Closed	-$631K	–	706
2020 Q3	$631K	Buy	+12,020	New	+$498K	0.14%	287

Seven Eight Capital's MNTA Position: Q4 2020 in Review

Seven Eight Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 12,020 shares — an estimated $631K sold.

Seven Eight Capital first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $631K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Seven Eight Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Seven Eight Capital sold 12,020 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $631K.
Seven Eight Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Seven Eight Capital's Momenta Pharmaceuticals, Inc. position peaked at $631K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.